Related Experiment Videos
Management of disseminated kidney cancer
S S Taneja1, W Pierce, R Figlin
1Division of Urology, University of California, Los Angeles School of Medicine.
The Urologic Clinics of North America
|November 1, 1994
Abstract:
The approach to disseminate renal cell carcinoma (RCC) has evolved significantly in recent years, largely owing to the progress of biologic therapy development. With increasing knowledge of biologic therapy come several dilemmas, including the choice of cytokine therapy, the appropriate mode of delivery, the selection of candidates for given therapeutic options, and the role of cytoreductive nephrectomy in immunotherapy protocols. This article reviews the historical development of immunotherapy and the lessons learned from previous experience and offers a logical approach to the patient with disseminated RCC.